News

Oncology: infrared light could help surgeons see more clearly the tumors during operations

Published on 21 June 2021

Groningen, the Netherlands, and Nantes, France   The University Medical Center Groningen and Kaer Labs... Read more

Siemens acquires Nextflow Software to speed simulations with advanced meshless technology

Published on 4 June 2021

• Siemens to integrate Nextflow Software’s meshless CFD technology into the Xcelerator software portfolio for... Read more

Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

Published on 22 April 2021

Valneva, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for... Read more

Non-hormonal female contraception using antibody fragments

Published on 19 April 2021

Accelerating Discovery for Non-Hormonal Contraceptives is one of the Grand Challenge programmes launched by the... Read more

GoLiver Therapeutics is the winner of the French Government‘s «Recovery plan for the industry – strategic sectors» call for the implementation of its industrial manufacturing platform project aimed at developing a biomedicine from pluripotent stem cells

Published on 22 March 2021

The aim of this project is to manufacture, in France, a cell therapy product from... Read more

Valneva Joins Euronext SBF 120 and CAC Mid 60 Indices

Published on 22 March 2021

Saint-Herblain (France), March 22, 2021 – Valneva SE, a specialty vaccine company focused on the development and... Read more

Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate

Published on 22 February 2021

Valneva, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical... Read more

Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment

Published on 28 January 2021

Saint-Herblain (France), January 28, 2021 – Valneva SE, a specialty vaccine company focused on prevention of infectious... Read more

Valneva in Advanced Discussions with European Commission to Supply up to 60 Million Doses of Inactivated, Adjuvanted COVID-19 Vaccine Candidate

Published on 12 January 2021

Saint-Herblain (France), January 12, 2021 – Valneva SE, a specialty vaccine company focused on prevention of infectious... Read more

INNOVATIVE OUTBOARD WINS DAME R&D EXCELLENCE IN ADVERSITY AWARD

Published on 14 December 2020

Andre Hoek, Chair of the DAME Jury, presented the very special one-off prize to the... Read more